Journal
JOURNAL OF NEUROSCIENCE
Volume 32, Issue 14, Pages 4841-4847Publisher
SOC NEUROSCIENCE
DOI: 10.1523/JNEUROSCI.5328-11.2012
Keywords
-
Categories
Funding
- Canadian Institutes of Health Research (CIHR)
- Multiple Sclerosis Society of Canada
Ask authors/readers for more resources
How iron is delivered to the CNS for myelination is not well understood. We assessed whether astrocytes can provide iron to cells in the CNS for remyelination. To study this we generated a conditional deletion of the iron efflux transporter ferroportin (Fpn) in astrocytes, and induced focal demyelination in the mouse spinal cord dorsal column by microinjection of lysophosphatidylcholine (LPC). Remyelination assessed by electron microscopy was reduced in astrocyte-specific Fpn knock-out mice compared with wild-type controls, as was proliferation of oligodendrocyte precursor cells (OPCs). Cell culture work showed that lack of iron reduces the ability of microglia to express cytokines (TNF-alpha and IL-1 beta) involved in remyelination. Furthermore, astrocytes in culture express high levels of FGF-2 in response to IL-1 beta, and IGF-1 in response to TNF-alpha stimulation. FGF-2 and IGF-1 are known to be important for myelination. Reduction in IL-1 beta and IGF-1 were also seen in astrocyte-specific Fpn knock-out mice after LPC-induced demyelination. These data suggest that iron efflux from astrocytes plays a role in remyelination by either direct effects on OPCs or indirectly by affecting glial activation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available